Breast Cancer: HOMING Study: Harvest of Circulating Tumor Cells (CTCs) from Patients
with Metastatic Breast Cancer (MBC) using the Parsortix PC1 System
Can the new Parsortix PC1 system capture and harvest CTCs (circulating tumor cells)
from blood and show that the cells can be used for different types of subsequent evaluations
including cancer related gene expression evaluations?
Basic Study Information
Purpose:Location: Cancer Center
If you participate in this study, you will be asked to allow the study doctor to draw
3 tubes of blood (up to a total of 23mL or 1 1/2 tablespoons of your blood) for the
evaluation of the presence or absence of CTCs and their characterization as well as
to collect information about your health.
Study Reference #: UBRS17062
Lead Researcher (Principal Investigator)
Lead Researcher: Richard Moore
Study Contact InformationStudy Coordinator: Erika Bronk
Phone: (585) 275-1561
Additional Study Details
Learn More About These Conditions
More information about Breast Cancer
Trial Not Found
The study you are looking for is not active at this time.
Return to Search